Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childre
Phase 2
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2022/01/039863
- Lead Sponsor
- Dr S Surendar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body
Exclusion Criteria
1.Children above 12 years
2.Children below 3 years
3.Albinism
4.Pie-baldism
5.Hypo pigmented patches start firstly in lips and genital area
6.Depigemented patches after burns
7.Juvenile diabetes with vitiligo
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method